Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase subunit beta, bacterial-type, is a core enzymatic subunit of the bacterial RNA polymerase complex encoded by the rpoB gene[2][6][7]. It forms part of the active center responsible for the catalysis of RNA synthesis during transcription, working in concert with the beta', alpha, and omega subunits to convert DNA sequences into RNA transcripts[2][3][4][5]. The beta subunit is essential for life in bacteria and is directly targeted by antibiotics like rifampicin, making it a crucial focus for antibacterial drug design and resistance profiling[4][3][7].
Inhibition of RNA polymerase activity by preventing initiation or elongation of RNA synthesis (e.g., rifampicin binds to the beta subunit, blocking the RNA exit tunnel and preventing RNA chain elongation[4][3][7]) Disruption of the formation or function of the transcriptional machinery
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase subunit beta, bacterial-type.